Overview

A Study to Investigate the Pharmacokinetic Profile of Oral AB680 in Healthy Volunteers

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
A Double-Blind, Randomized, Placebo-Controlled, Single Ascending Dose Study to Investigate the Pharmacokinetic Profile of Oral AB680 in Healthy Volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Arcus Biosciences, Inc.